Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kengo Yonezawa"'
Autor:
Hideaki Tani, Kengo Yonezawa, Keisuke Kusudo, Frederick S. Barrett, Shinichiro Nakajima, Hiroyuki Uchida
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 3, Pp 534-539 (2024)
Abstract Introduction The therapeutic potential of psychedelics for various mental disorders has gained significant interest. Previous studies have highlighted that psychedelics induce psychoactive effects, including challenging aspects of experience
Externí odkaz:
https://doaj.org/article/4fbe0392c3be45d3a1180fad4c5b321a
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 280-284 (2024)
Abstract Introduction Psychedelics have garnered increased attention as potential therapeutic options for various mental illnesses. Previous studies reported that psychedelics cause psychoactive effects through mystical experiences induced by these s
Externí odkaz:
https://doaj.org/article/ed97a903da7941149e530431b618325c
Autor:
Keisuke Kusudo, Hideaki Tani, Kengo Yonezawa, Shinichiro Nakajima, Matthew M. Nour, Robin Carhart‐Harris, Hiroyuki Uchida
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 292-297 (2024)
Abstract Aim Psychedelics have recently gained attention as potential therapeutic agents for various psychiatric disorders. Previous research has highlighted that a diminished sense of self, commonly termed “ego‐dissolution” is a pivotal featur
Externí odkaz:
https://doaj.org/article/54c62a26ad1c4586955ee7cbac5a5b7d
Publikováno v:
Pharmacopsychiatry. 55(4)
Introduction There is an imminent need for faster-acting and more effective antidepressants beyond the monoaminergic hypothesis. Methods We systematically searched the US Clinical Trials registry for antidepressant compounds with completed phase II a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3d99a925d7a09612e8a34ca4845657
https://pubmed.ncbi.nlm.nih.gov/35045580
https://pubmed.ncbi.nlm.nih.gov/35045580
Autor:
Kengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, Nobuhiro Nagai, Teruki Koizumi, Tomoyuki Miyazaki, Masaru Mimura, Takuya Takahashi, Hiroyuki Uchida
Publikováno v:
Schizophrenia research. 243
While altered expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type receptor has been reported in postmortem studies of schizophrenia, these findings are inconsistent. Therefore, we aimed to systematically review postmortem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d800ff099439bdb25f5227f574fb19
https://pubmed.ncbi.nlm.nih.gov/35247795
https://pubmed.ncbi.nlm.nih.gov/35247795